Status:
COMPLETED
The Role of Fibroblast Activation in Uterine Fibroid
Lead Sponsor:
Assiut University
Conditions:
Uterine Fibroid
Eligibility:
FEMALE
Up to 50 years
Brief Summary
Uterine fibroids (UFs), also called uterine leiomyomas or myomas, are steroid hormone-responsive, benign tumors of the smooth muscle compartment (myometrium) of the uterus. They are the most common ne...
Detailed Description
* Uterine fibroids (UFs) are steroid hormone-responsive, benign tumors of the smooth muscle compartment (myometrium) of the uterus .They are the most common neoplasm affecting women in their reproduct...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- i. Premenopausal women (age ˂ 50) with uterine fibroids who are diagnosed through clinical gynecological, ultrasound and other auxiliary examinations.
- ii. Patients who exhibit a normal coagulation function.
- Exclusion Criteria
- i. Patients who have a previous history of myomectomy or with ovarian malignancy and borderline tumors ii. Patients who are subsequently diagnosed with uterine adenomyosis. iii. Pregnant women. iv. Patients who receive hormonal treatment within three months before surgery. v. Patients with history of coronary artery disease, hypertension, liver cirrhosis or hematologic disorders.
Exclusion
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03444987
Start Date
March 1 2018
End Date
March 1 2020
Last Update
February 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university -Faculty of medicine- Departement of Biochemistry
Asyut, Egypt, 71111